Cheiljedang released breast cancer drug, Genexol to market.

Cheiljedang announced that Paclitaxel preparation, the first domestic anti-breast cancer drug, was ready to release its sales on the market, the main ingredient of which was originally developed by Samyang in a massive production with unformed quality via a plant cultural technology, and now made a joint business tie-up with Samyang for sales.

Cheiljedang said that Genexol, a Taxane derivati...